Hinge Health (NYSE:HNGE) Issues Earnings Results, Beats Estimates By $0.44 EPS

Hinge Health (NYSE:HNGE) released its quarterly earnings results on Monday. The company reported $0.71 EPS for the quarter, topping the consensus estimate of $0.27 by $0.44, FiscalAI reports. Hinge Health had a return on equity of 51.60% and a net margin of 15.15%. The company had revenue of $234.97 million for the quarter. During the same period last year, the firm earned ($0.02) EPS. The company’s quarterly revenue was up 52.4% on a year-over-year basis.

Here are the key takeaways from Hinge Health’s conference call:

• Q3 results exceeded expectations, with revenue up 52% year over year to $235 million, an 88% gross margin, a 33% operating margin, and $120 million in free cash flow. The company raised its full-year 2026 revenue guidance to $879 million–$881 million and operating income guidance to $266 million–$268 million.
• Commercial momentum accelerated, with contracted clients up 28% year over year to 3,270, nearly 1 million SMB lives added through Q3, and more than 10 million lives across over 800 clients gaining access to multiple Hinge Health products. Management also cited rising win rates, strong health-plan partnerships, and increased member enrollment and renewals.
• Early results from the Migraine Care Program were encouraging, including a 23% reduction in monthly migraine days, a 28% reduction in attack duration, and clinically meaningful HIT-6 improvements for more than half of surveyed members. Migraine access has expanded to roughly 9 million lives, with most launches expected in early 2027.
• Hinge plans to launch its integrated GI Care Program in summer 2027, but management expects the offering’s revenue contribution to become meaningful mainly in 2028. The company is currently selling Cylinder’s existing GI solution and has expanded its GI client base by approximately 40% since announcing the acquisition.
• President Jim Pursley will step down at year-end to spend more time with his family and join Hinge Health’s board, with Chief Commercial Officer Aaryn Pure taking over go-to-market leadership. Management characterized the transition as orderly, but the change introduces leadership-transition risk.

Hinge Health Stock Performance

Shares of HNGE opened at $115.11 on Tuesday. The stock has a market capitalization of $9.29 billion, a P/E ratio of 89.93 and a beta of 1.37. The company’s fifty day moving average is $98.66 and its two-hundred day moving average is $67.35. Hinge Health has a 1 year low of $30.08 and a 1 year high of $118.87.

Key Stories Impacting Hinge Health

Here are the key news stories impacting Hinge Health this week:

• Positive Sentiment: Quarterly results exceeded consensus. Hinge Health generated approximately $235.0 million in revenue, up 52.4% year over year, and reported $0.71 in earnings per share versus estimates ranging from $0.27 to $0.63. The company also posted a 15.15% net margin, reinforcing the improving profitability story. Hinge Health reports record third quarter 2026 financial results
• Positive Sentiment: Management provided a constructive growth outlook. Hinge Health outlined 2026 revenue of $879 million to $881 million, representing another upward outlook adjustment according to coverage of the earnings call. The company also is targeting an integrated gastrointestinal care program for summer 2027, creating a potential new expansion opportunity beyond its core musculoskeletal business. Hinge Health outlines revenue outlook and GI program
• Neutral Sentiment: The earnings reaction was relatively limited. Although Hinge Health cleared published estimates and highlighted record results, reports characterized the stock’s response as muted. With a market capitalization near $9.3 billion, a price-to-earnings ratio around 89, and shares close to their one-year high, much of the strong execution may already be reflected in the valuation. Hinge Health third-quarter results beat forecasts
• Negative Sentiment: Expectations remain a key risk. Some coverage indicated that results missed the higher “whisper” forecast despite beating official consensus estimates. That gap, combined with the stock’s sharp appreciation above its 50-day and 200-day moving averages, could limit further gains unless Hinge Health continues delivering sizable revenue growth and upward guidance revisions. Hinge Health clears consensus but misses the whisper

Insider Activity

In other news, CEO Daniel Perez sold 150,000 shares of the firm’s stock in a transaction on Thursday, September 10th. The shares were sold at an average price of $89.44, for a total value of $13,416,000.00. Following the completion of the sale, the chief executive officer owned 35,470 shares in the company, valued at approximately $3,172,436.80. This trade represents a 80.88% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Chairman Gabriel Mecklenburg sold 250,000 shares of Hinge Health stock in a transaction dated Friday, September 11th. The shares were sold at an average price of $88.97, for a total transaction of $22,242,500.00. Following the completion of the sale, the chairman directly owned 250,000 shares in the company, valued at approximately $22,242,500. The trade was a 50.00% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 1,024,581 shares of company stock worth $95,632,761 in the last 90 days. Corporate insiders own 18.92% of the company’s stock.

Institutional Investors Weigh In On Hinge Health

Institutional investors have recently added to or reduced their stakes in the business. IFP Advisors Inc raised its stake in shares of Hinge Health by 140.0% during the 2nd quarter. IFP Advisors Inc now owns 324 shares of the company’s stock worth $27,000 after buying an additional 189 shares in the last quarter. Nykredit A S acquired a new stake in shares of Hinge Health in the 2nd quarter valued at approximately $29,000. SBI Securities Co. Ltd. boosted its stake in shares of Hinge Health by 39.5% in the third quarter. SBI Securities Co. Ltd. now owns 364 shares of the company’s stock valued at $35,000 after buying an additional 103 shares in the last quarter. State of Wyoming purchased a new stake in shares of Hinge Health in the first quarter valued at approximately $110,000. Finally, Sterling Capital Management LLC boosted its stake in shares of Hinge Health by 899.3% in the third quarter. Sterling Capital Management LLC now owns 1,469 shares of the company’s stock valued at $143,000 after buying an additional 1,322 shares in the last quarter.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on HNGE shares. Royal Bank Of Canada increased their price target on shares of Hinge Health from $75.00 to $110.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 5th. Barclays increased their target price on shares of Hinge Health from $100.00 to $110.00 and gave the stock an “overweight” rating in a research note on Monday, October 12th. Truist Financial boosted their price target on Hinge Health from $85.00 to $112.00 and gave the company a “buy” rating in a research report on Monday, August 10th. Stifel Nicolaus boosted their price target on Hinge Health from $130.00 to $135.00 and gave the company a “buy” rating in a research report on Tuesday. Finally, Evercore reaffirmed an “outperform” rating and set a $105.00 price objective on shares of Hinge Health in a research note on Wednesday, August 5th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, Hinge Health has a consensus rating of “Moderate Buy” and an average target price of $111.60.

About Hinge Health

Hinge Health is a digital healthcare company focused on musculoskeletal (MSK) conditions, including back and joint pain. The company provides virtual care programs designed to help members manage pain, improve mobility and reduce the need for more costly or invasive treatments.

Its platform combines personalized exercise therapy, behavioral support, education and access to clinical professionals. Hinge Health also uses technologies such as motion-sensing wearable devices and artificial intelligence to help guide exercises, monitor progress and tailor care plans to individual needs.

Hinge Health primarily serves employers and health plans, which offer its programs to eligible members in the United States.